These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22099718)

  • 41. Pharmaceuticals and medical devices: business practices. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-44. PubMed ID: 21374840
    [No Abstract]   [Full Text] [Related]  

  • 42. Health technology assessment for medical devices in Europe. What must be considered.
    Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW;
    Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurology and medical devices.
    Johnston SC; Hauser SL
    Ann Neurol; 2006 Oct; 60(4):11A-2A. PubMed ID: 17068793
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical practice guidelines: a review.
    Hayes OW
    J Am Osteopath Assoc; 1994 Sep; 94(9):732-8. PubMed ID: 7995736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experiences of new product development in the medical device industry.
    Dixon D; Brown A; Meenan BJ; Eatock J
    Med Device Technol; 2006 Apr; 17(3):20-2. PubMed ID: 16736659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physicians and the pharmaceutical industry (update 1994). Canadian Medical Association.
    CMAJ; 1994 Jan; 150(2):256A-256F. PubMed ID: 8287348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Economical evaluation of drugs. A steering method for the pharmaceutical sector of the 1990's?].
    Grund J; Husbyn H
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):947-50. PubMed ID: 8191475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Forces reshaping the performance and contribution of the U.S. medical device industry.
    Benson JS
    Food Drug Law J; 1996; 51(2):331-6. PubMed ID: 11822326
    [No Abstract]   [Full Text] [Related]  

  • 49. Working together to enhance the efficiency of medical product development.
    Sanhai WR
    J Nucl Med; 2008 Jun; 49(6):43N-45N. PubMed ID: 18511823
    [No Abstract]   [Full Text] [Related]  

  • 50. Is FDA's medical device evaluation process overly complaisant to industry?
    Margolis RE
    Healthspan; 1992; 9(7):19-20. PubMed ID: 10121440
    [No Abstract]   [Full Text] [Related]  

  • 51. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. American academy of pain medicine ethics council statement on conflicts of interest: interaction between physicians and industry in pain medicine.
    Dubois MY;
    Pain Med; 2010 Feb; 11(2):257-62. PubMed ID: 19930112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Few US medical schools and medical centres are disclosing industry ties.
    Tanne JH
    BMJ; 2010 Feb; 340():c1075. PubMed ID: 20179129
    [No Abstract]   [Full Text] [Related]  

  • 54. Current guidelines regarding industry-sponsored continuing medical education.
    DelSignore JL
    Clin Orthop Relat Res; 2003 Jul; (412):21-7. PubMed ID: 12838047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequently asked questions regarding the revised Advanced Medical Technology Association (AdvaMed) Code of Ethics on Interactions with Health Care Professionals.
    Optometry; 2009 May; 80(5):262-6. PubMed ID: 19418651
    [No Abstract]   [Full Text] [Related]  

  • 56. Future directions in industry funding of continuing medical education.
    Steinbrook R
    Arch Intern Med; 2011 Feb; 171(3):257-8. PubMed ID: 21325116
    [No Abstract]   [Full Text] [Related]  

  • 57. Special report of the Joint Committee on Government Relations.
    Matloff JM
    Ann Thorac Surg; 1995 Sep; 60(3):740-3. PubMed ID: 7677524
    [No Abstract]   [Full Text] [Related]  

  • 58. Interaction between optometrists and health care device industry representatives.
    Optometry; 2009 May; 80(5):255-61. PubMed ID: 19418650
    [No Abstract]   [Full Text] [Related]  

  • 59. Relations between professional medical associations and the healthcare industry, concerning scientific communication and continuing medical education--a policy statement from the European Society of Cardiology.
    European Society of Cardiology
    Acta Cardiol; 2012 Apr; 67(2):265-71. PubMed ID: 22641990
    [No Abstract]   [Full Text] [Related]  

  • 60. Education or promotion?: Industry-sponsored continuing medical education (CME) as a center for the core/commercial speech debate.
    Chen P;
    Food Drug Law J; 2003; 58(3):473-509. PubMed ID: 14626981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.